Asaf Maoz

Oncology

300 Boylston St
Chestnut Hill, MA 02467

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Genomic characterization of therapy-associated polyposis reveals an alkylating mutational signature from prior treatment.

Genomic characterization of therapy-associated polyposis reveals an alkylating mutational signature from prior treatment.

Journal: The Journal of clinical investigation

Published: August 04, 2026

Prospective Study of Annual Whole-Body Magnetic Resonance Imaging as Part of a Multimodality Screening Program for Individuals With Li-Fraumeni Syndrome.

Prospective Study of Annual Whole-Body Magnetic Resonance Imaging as Part of a Multimodality Screening Program for Individuals With Li-Fraumeni Syndrome.

Journal: JCO precision oncology

Published: October 23, 2025

Causes of Death Among Individuals With Lynch Syndrome in the Immunotherapy Era.

Causes of Death Among Individuals With Lynch Syndrome in the Immunotherapy Era.

Journal: JCO precision oncology

Published: October 11, 2025

Colorectal neoplasia rates in Li Fraumeni Syndrome.

Colorectal neoplasia rates in Li Fraumeni Syndrome.

Journal: The American journal of gastroenterology

Published: October 05, 2025

Intratumoral Heterogeneity of Mismatch Repair Status and Outcome of Treatment With Dostarlimab in a Patient With Locally Advanced Rectal Adenocarcinoma.

Intratumoral Heterogeneity of Mismatch Repair Status and Outcome of Treatment With Dostarlimab in a Patient With Locally Advanced Rectal Adenocarcinoma.

Journal: JCO precision oncology

Published: April 28, 2025

Leveraging Electronic Health Record Data to Understand Gaps Underlying the Underdiagnosis of Lynch Syndrome.

Leveraging Electronic Health Record Data to Understand Gaps Underlying the Underdiagnosis of Lynch Syndrome.

Journal: JCO clinical cancer informatics

Published: June 05, 2024

Gastrointestinal Cancer Precursor Conditions and Their Detection.

Gastrointestinal Cancer Precursor Conditions and Their Detection.

Journal: Hematology/oncology clinics of North America

Published: May 17, 2024

Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11-Mutant Non-Small-Cell Lung Cancer.

Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11-Mutant Non-Small-Cell Lung Cancer.

Journal: JCO precision oncology

Published: February 08, 2024

Phagocytic cooperativity by tumour macrophages.

Phagocytic cooperativity by tumour macrophages.

Journal: Nature biomedical engineering

Published: September 07, 2023

Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden.

Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden.

Journal: Journal for immunotherapy of cancer

Published: July 30, 2023

Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer.

Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer.

Journal: Frontiers in immunology

Published: July 27, 2023

Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.

Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.

Journal: bioRxiv : the preprint server for biology

Published: March 22, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026